Table 2.
Chest imaging findings and laboratory indices.
| Variables | All patients (N = 125) |
|---|---|
| Chest computed tomography | |
| Total abnormalities, N (%) | 85 (68.0%) |
| Ground-glass opacity | 70 (56.0%) |
| Local patchy shadowing | 18 (14.4%) |
| Bilateral patchy shadowing | 10 (8.0%) |
| Interstitial abnormalities | 4 (3.2%) |
| Complete blood counts | |
| Leukocyte count | 6.4 (5.3–7.4) |
| >10 × 109/L | 2 (2.1%) |
| <4 × 109/L | 6 (4.8%) |
| Lymphocyte count | 2.0 (1.6–2.3) |
| <1.5 × 109/L | 21 (16.8%) |
| Platelet count | 216 (172–261) |
| <150 × 109/L | 15 (12%) |
| Hemoglobin level, g/L | 145 (139–152) |
| Hepatic and renal functions | |
| AST > 40 U/L, N (%) | 14 (11.2%) |
| AST > 80 U/L, N (%) | 1 (0.8%) |
| ALT > 40 U/L, N (%) | 60 (48.0%) |
| ALT > 80 U/L, N (%) | 16 (12.8%) |
| TB 17.1 μmol/L, N (%) | 7 (0.56%) |
| Creatinine ≥ 133 μmol/L, N (%) | 0 (0%) |
| Blood biochemistry | |
| Sodium, mmol/L | 140.3 (138.4–141.8) |
| Potassium, mmol/L | 4.65 (4.34–5.0) |
| Chloride, mmol/L | 100.3 (99.1–101.5) |
| CRP ≥ 10 mg/L, N (%) | 10 (8.0%) |
| LDH ≥ 250 U/L, N (%) | 1 (0.8%) |
| CK ≥ 200 U/L, N (%) | 4 (0.32) |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; TB, total bilirubin; CRP, C-reactive protein; LDH, lactose dehydrogenase; CK, creatine kinase. Non-normally distributed continuous variables were presented as median and interquartile range (IQR): median (IQR). Categorical variables were presented as number and percentage: number (percentage).